The AQUARIUS study tested whether a drug called aliskiren could slow the progression of coronary artery disease (CAD) in patients with slightly high blood pressure. The study compared aliskiren to a placebo, with both groups also receiving standard heart disease treatments. Researchers used a special ultrasound to measure changes in the patients’ artery health over two years.
[button title=”Read Study” link=”https://clinicaltrials.gov/study/NCT00853827″ target=”_blank” align=”” icon=”” icon_position=”” color=”” font_color=”” size=”2″ full_width=”” class=”” download=”” rel=””]